
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.040 | 3.240 | 0.200 |
Shares | 96.960 | 96.960 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 35.074 | 30.988 |
Price to Book | 4.167 | 3.619 |
Price to Sales | 6.286 | 4.995 |
Price to Cash Flow | 27.001 | 19.840 |
Dividend Yield | 0.516 | 0.743 |
5 Years Earnings Growth | 22.749 | 17.877 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 93.190 | 95.956 |
Basic Materials | 6.810 | 5.710 |
Number of long holdings: 31
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.45 | 1,747.40 | +0.14% | |
Max Healthcare Institute | INE027H01010 | 6.68 | 1,128.70 | +5.19% | |
Divi's Labs | INE361B01024 | 6.00 | 5,911.50 | +0.34% | |
Cipla | INE059A01026 | 4.79 | 1,528.20 | +1.13% | |
Lupin | INE326A01037 | 4.72 | 2,046.70 | +1.87% | |
Lonza Group AG | US54338V1017 | 4.38 | 67.35 | +3.08% | |
Mankind Pharma | INE634S01028 | 3.76 | 2,575.55 | -0.31% | |
Krishna Institute of Medical Sciences | INE967H01025 | 3.72 | 683.60 | +3.46% | |
Jupiter Life Line Hospitals | INE682M01012 | 3.54 | 1,501.70 | +2.27% | |
Ami Organics | INE00FF01017 | 3.38 | 2,191.50 | -3.29% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SBI Magnum Balanced Fund Direct Div | 684.4B | 1.82 | 12.09 | 12.32 | ||
SBI Magnum Balanced Fund Direct Gro | 684.4B | 1.82 | 12.09 | 12.40 | ||
SBI Magnum Balanced Fund Regular Gr | 684.4B | 1.66 | 11.34 | 11.45 | ||
SBI Magnum Balanced Reg Div Payout | 684.4B | 1.66 | 11.34 | 11.37 | ||
SBI Bluechip Fund Regular Dividend | 461.4B | -1.39 | 12.89 | 11.78 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review